Expertise in
11
conditions

Jeremie Sellam

Paris, FR 
Expertise in
11
conditions
Paris, FR 

Overview

Jeremie Sellam practices practicing medicine in Paris, France.

Mr. Sellam is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Arthritis, Osteoarthritis, Rheumatoid Arthritis (RA), Vitrectomy, and Knee Replacement.

He is actively involved in clinical research, co-authoring 208 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
Montpellier, France
Clermont-ferrand, France
Saint Antoine, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Combination of Baricitinib and Anti-TNF vs. Baricitinib in Patients With Rheumatoid Arthritis: a Randomized Controlled Phase III Trial
Combination of Baricitinib and Anti-TNF vs. Baricitinib in Patients With Rheumatoid Arthritis: a Randomized Controlled Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, Adalimumab
Study Phase: Phase 3
Trial of Auricular Vagus Nerve Stimulation in Painful and Inflammatory Erosive Hand Osteoarthritis
Trial of Auricular Vagus Nerve Stimulation in Painful and Inflammatory Erosive Hand Osteoarthritis
Enrollment Status: Completed
Publish Date: September 16, 2025
Intervention Type: Device
Study Phase: Not Applicable
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 18, 2024
Intervention Type: Drug, Biological
Study Drugs: Secukinumab, TNF blocker, Blood specimen
Study Phase: Phase 4
Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T
Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Device
View 3 Less Clinical Trials

207 Total Publications

Atopy is associated with osteoarthritis severity: results from the KHOALA cohort.
Atopy is associated with osteoarthritis severity: results from the KHOALA cohort.
Journal: Joint bone spine
Published: May 08, 2026

Frequently Asked Questions about Jeremie Sellam

Is Jeremie Sellam a top-rated expert for Arthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Jeremie Sellam is classified as an Elite expert for Arthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jeremie Sellam participate in research or clinical trials?

Yes. Jeremie Sellam has published 207 articles and abstracts on conditions like Arthritis. You can view a list of Jeremie Sellam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sellam's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile